Depei Wu

5.9k total citations · 1 hit paper
219 papers, 3.0k citations indexed

About

Depei Wu is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Depei Wu has authored 219 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Hematology, 65 papers in Oncology and 54 papers in Molecular Biology. Recurrent topics in Depei Wu's work include Acute Myeloid Leukemia Research (68 papers), Hematopoietic Stem Cell Transplantation (61 papers) and Acute Lymphoblastic Leukemia research (36 papers). Depei Wu is often cited by papers focused on Acute Myeloid Leukemia Research (68 papers), Hematopoietic Stem Cell Transplantation (61 papers) and Acute Lymphoblastic Leukemia research (36 papers). Depei Wu collaborates with scholars based in China, United States and France. Depei Wu's co-authors include Xiaowen Tang, Suning Chen, Yue Han, Xiao‐Jun Huang, Yang Xu, Qifa Liu, Lan‐Ping Xu, Aining Sun, Xiaojin Wu and Kai‐Yan Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Depei Wu

192 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

2021 150 citations Xiaohui Zhang, Erlie Jiang et al. profile →

Peers

Countries citing papers authored by Depei Wu

Since Specialization

Citations

This map shows the geographic impact of Depei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Depei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Depei Wu more than expected).

Fields of papers citing papers by Depei Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Depei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Depei Wu. The network helps show where Depei Wu may publish in the future.

Co-authorship network of co-authors of Depei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Depei Wu. A scholar is included among the top collaborators of Depei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Depei Wu. Depei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expansion of peripheral helper T cells in the peripheral blood of patients with chronic graft-versus-host disease 2025 ·Annals of Hematology ·Yuanyuan Du, (unknown), (unknown), (unknown), Mimi Xu, Li Wan, Meng Zhou, (unknown), Chengyuan Gu, Ruju Wang, Yue Han, Yongxia Wu, Depei Wu, Yuejun Liu	0
2	Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP 2025 ·American Journal of Hematology ·Ali Bazarbachi, Jacques‐Emmanuel Galimard, (unknown), Gérard Socié, (unknown), Depei Wu, Matthias Eder, Hélène Labussière‐Wallet, Ibrahim Yakoub‐Agha, Johan Maertens, (unknown), Tobias Gedde‐Dahl, Goda Choi, Cristina Castilla‐Llorente, Frédéric Baron, Éolia Brissot, Jordi Esteve, (unknown), (unknown), (unknown)	0
3	Review of the role of submucosal injection materials in digestive endoscopy 2025 ·Annals of Medicine ·Depei Wu, (unknown), Zhice Xu, (unknown), (unknown), (unknown)	0
4	Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma 2025 ·Scientific Reports ·(unknown), (unknown), (unknown), Yan Chen, (unknown), (unknown), Jiannong Cen, Jinlan Pan, Lingzhi Yan, Jingjing Shang, Song Jin, (unknown), (unknown), Shuang Yan, Zixing Chen, Depei Wu, Suning Chen, Chengcheng Fu, (unknown)	0
5	Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia 2025 ·Clinical Lymphoma Myeloma & Leukemia ·Zhibo Zhang, Jia Yin, Jun Wang, Xuefeng He, Xiaohui Hu, Haiwen Huang, Limin Liu, Miao Miao, Ying Wang, Huiying Qiu, Xiaowen Tang, Depei Wu, Xiao Ma, Weiyang Li	0
6	DIAPH1 mutations predict a favorable outcome for de novo MDS 2024 ·Cancer Letters ·(unknown), Hong Wang, Ziyan Zhang, (unknown), Yue Han, Depei Wu	1
7	Efficacy and Safety of Gilteritinib-Based Therapy Combinated with Allo-HSCT in Relapsed or Refractory Acute Myeloid Leukemia Patients with Positive FLT3-ITD Mutation 2024 ·Blood ·Jian Zhang, Yang Xu, Shengli Xue, Miao Miao, Ying Wang, Suning Chen, Depei Wu, Huiying Qiu	0
8	The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping 2024 ·Annals of Hematology ·Xiaojin Wu, (unknown), (unknown), Jie Liu, Yi Sun, Depei Wu	3
9	Evaluation of the Diagnostic Performance of Plasma Metagenomic Next-Generation Sequencing in Febrile Events in the First 30 Days after Chimeric Antigen Receptor T Cell Infusion 2023 ·Transplantation and Cellular Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jie Xu, Depei Wu, Yang Xu	1
10	Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT 2023 ·Bone Marrow Transplantation ·(unknown), Myriam Labopin, Thomas Pabst, Xi Zhang, Erlie Jiang, Alessandra Tucci, Jan J. Cornelissen, Ellen Meijer, (unknown), Emmanuelle Polge, Depei Wu, Mohamad Mohty, Norbert Claude Gorin	4
11	HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma 2022 ·Biomedicines ·Wenjie Gong, Lei Wang, Maria‐Luisa Schubert, Christian Kleist, Brigitte Neuber, Sanmei Wang, Mingya Yang, Angela Hückelhoven‐Krauss, Depei Wu, Anita Schmitt, Carsten Müller‐Tidow, Hiroshi Shiku, Michael Schmitt, Leopold Sellner	4
12	Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells 2021 ·Cells ·Wenjie Gong, Lei Wang, Sophia Stock, Ming Ni, Maria‐Luisa Schubert, Brigitte Neuber, Christian Kleist, Angela Hückelhoven‐Krauss, Depei Wu, Carsten Müller‐Tidow, Anita Schmitt, Hiroshi Shiku, Michael Schmitt, Leopold Sellner	4
13	DLL1 orchestrates CD8⁺T cells to induce long-term vascular normalization and tumor regression 2021 ·Proceedings of the National Academy of Sciences ·Naidong Zhang, (unknown), Pei Zhou, Xiaomei Liu, Peng Fan, (unknown), (unknown), Chenglin Zhang, Xichen Zheng, Shengming Deng, (unknown), Zhenhua Liu, Wen Jiang, Xiaohua Wang, Depei Wu, Yuhui Huang	40
14	Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation 2020 ·Bone Marrow Transplantation ·(unknown), Jian Zhang, Xinyou Zhang, (unknown), Lili Zhou, Xiebing Bao, Yue Han, Miao Miao, Caixia Li, Chengcheng Fu, Suning Chen, Xiaowen Tang, Depei Wu, Huiying Qiu	21
15	Investigation of the Potential Mechanism Governing the Effect of the Shen Zhu San on COVID‐19 by Network Pharmacology 2020 ·Evidence-based Complementary and Alternative Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Xiaohe Sun, (unknown), (unknown), Hui Li, Zhigang Lu, Depei Wu, Minghua Wu	7
16	IL-Y Aggravates Murine Chronic Graft-Versus-Host Disease by Enhancing T and B Cell Responses 2020 ·Frontiers in Immunology ·Li Wan, Ziqi Jin, Bo Hu, (unknown), Lei Lei, Yonghao Liu, (unknown), Yuan Song, Ying Zhu, Huanle Gong, Mimi Xu, (unknown), Yang Xu, Haiyan Liu, Depei Wu, Yuejun Liu	8
17	Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry 2018 ·Blood ·Mohamed A. Yassin, Alì Taher, Vikram Mathews, Hsin‐An Hou, Tahir Shamsi, Tülin Tuğlular, Zhijian Xiao, Soo‐Jeong Kim, Depei Wu, Junmin Li, Gerd Rippin, (unknown), (unknown), Raymond Wong	2
18	Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study 2016 ·Clinical Cancer Research ·Yu Wang, Qifa Liu, Lan‐Ping Xu, Kai‐Yan Liu, Xiaohui Zhang, Xiao Ma, Meiqing Wu, Depei Wu, Xiao‐Jun Huang	115
19	[Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area]. 2014 ·PubMed ·(unknown), Depei Wu, Zhaoyue Wang	3
20	Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia 2014 ·Leukemia & lymphoma ·(unknown), (unknown), (unknown), Huiquan Tao, Hong Liu, Suning Chen, (unknown), Depei Wu, Bin Yin	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact